Clinical Trials Sponsored by Shanghai Hengrui Pharmaceutical Co., Ltd.

Total 5131 results

Shanghai Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor

Cldn18.2-positive Advanced Solid Tumor

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial

Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

High-risk Non-muscle Invasive Bladder Cancer

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma

B-cell Non-Hodgkin's Lymphoma

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-7367 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors

Advanced Malignant Tumor

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Study of HRS2543 in Patients With Advanced Tumors

Advanced Tumors

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast Cancer

ER-Positive, HER2-Negative Breast Cancer

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-1905 in Healthy Subjects and Subjects With Mild Asthma

Asthma

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Enrolling by invitation

A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects

Alzheimer's Disease

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children

Preoperative Sedation of Children

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

Safety, Tolerability and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients.

Alzheimer's Disease

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty

Prevention of Venous Thrombosis After TKA

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer

Advanced Pancreatic Cancer

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Study of SHR-A1904 in Patients With Advanced Solid Cancer

Advanced Solid Cancer

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy

Postsurgical Pain Management

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

A Trial of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy.

Postsurgical Pain Management

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients

Alzheimer's Disease

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management

Thoracoscopic Lobectomy

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Phase 1 Study of SHR-A2102 in Subjects With Advanced Solid Tumors.

Advanced Or Metastatic Solid Tumor Malignancies

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma

Asthma

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Study of HR19024 in Subjects With Advanced Solid Tumor

Advanced Solid Tumor

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Study of SHR-1501 Alone or in Combination With BCG in Subjects With NMIBC

High-risk NMIBC

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS INJECTIONS OF SHR-1819 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Moderate to Severe Atopic Dermatitis
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors

Advanced Malignant Cancer

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Active, not recruiting

Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management

Total Knee Arthroplasty

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Enrolling by invitation

A Study of SHR-A1912 for Injection in Patients With B Cell Lymphomas

B Cell Lymphoma

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

A Trial of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects

Asthma

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）

Eosinophilic Granulomatosis With Polyangiitis

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Completed

A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration

Chronic Cough

China
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Unknown

The Efficacy and Safety of Daptomycin in the Treatment of Gram-positive Bacterial Infection.

Antibiotic

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

A Phase I Study of SHR -2001 in Healthy Subjects

Healthy

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

Study on Single and Multiple Atomization Inhalation of HRS-9821 Suspension for Inhalation in Healthy Subjects

Chronic Obstructive Pulmonary Disease

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Enrolling by invitation

A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough

Refractory Chronic Cough

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Completed

A Trial of SHR - 1906 in Healthy Subjects

Idiopathic Pulmonary Fibrosis

China
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Unknown

Comparison of Analgesic Effect and Prognosis of Butorphanol and Fentanyl in Patients With Mechanical Ventilation

Analgesia

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects

Prevention of Graft Rejection After Organ Transplantation

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Primary IgA Nephropathy

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Recruiting

Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Enrolling by invitation

Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects

Kidney Transplantation

China
Guangdong Hengrui Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject

IgA Nephropathy

China
Daewoong Pharmaceutical Co. LTD.
Shanghai Haini Pharmaceutical Co., Ltd.

Active, not recruiting

A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects

Phase 1 Study, Healthy Volunteers

China

Clinical Trials Sponsored by Shanghai Hengrui Pharmaceutical Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations